[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making...

SLP : 14.70 (+2.94%)
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

More than 1,400 participants across 65+ countries underscores accelerating adoption of model-informed workflows and growing demand for applied modeling expertise

SLP : 14.70 (+2.94%)
Simulations Plus: Fiscal Q2 Earnings Snapshot

Simulations Plus: Fiscal Q2 Earnings Snapshot

SLP : 14.70 (+2.94%)
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results

Revenue grew 8% with increases in both software and services

SLP : 14.70 (+2.94%)
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date

Conference call to be on Thursday, April 9, 2026, at 5 p.m. ET

SLP : 14.70 (+2.94%)
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling

Co-development initiatives to advance next-generation workflows, accelerate adoption, and expand the role of AI within model-informed drug development

SLP : 14.70 (+2.94%)
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD

Expert panel at the 2026 ASCPT Annual Meeting brings together leaders with industry and regulatory experience to explore practical, accountable AI implementation

SLP : 14.70 (+2.94%)
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment

SLP : 14.70 (+2.94%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 8, 2026 /PRNewswire/ --

SLP : 14.70 (+2.94%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 3, 2026 /PRNewswire/ --

SLP : 14.70 (+2.94%)

Barchart Exclusives

AMD Stock Is at Record Highs—and Why It’s Still Not Too Late to Buy
AMD’s investment case is supported by sustained demand for high-performance CPUs, rapid expansion in AI accelerators, a solid product roadmap. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.